FAMILIAL EXUDATIVE VITREORETINOPATHY: OUR EXPERIENCE VITREORRETINOPATÍA EXUDATIVA FAMILIAR: NUESTRA EXPERIENCIA

Purpose: To describe our experience in the diagnosis of Familial Exudative Vitreoretinopathy (FEVR) at its different clinical stages. We also report our outcomes in early treatment of this inherited disorder. Methods: Retrospective interventional and descriptive case series of 11 patients (17 eyes) affected by FEVR evaluated and treated in our hospital. Results: In our series, 33.3% of patients were classified as stage I, while 16.7% and 50% were classified as stage II and III, respectively. Visual acuity (VA) remained stable after treatment in stages I and II (mean VA was 0.8 and 0.4, respectively) but decreased in stage III. Conclusions: Early treatment of FERV may improve the visual prognosis and avoid complications such as subfoveal chronic exudation and vitreoretinal peripheral interphase contraction and fibrosis (Arch Soc Esp Oftalmol 2008; 83: 703-708).